Search clinical trials for: Oxaliplatin capecitabine

Total 3092 results

BeiGene

Active, not recruiting

Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma

Gastric, or Gastroesophageal Junction Adenocarcinoma

United States, China, Spain, Korea, Republic of, Poland, Russian Federation, Taiwan, France, Turkey, Japan, Italy, United Kingdom, Puerto Rico
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Unknown

Intraperitoneal and System Chemotherapy Versus XELOX as First-line Chemotherapy for mCRC

Colorectal Cancer Metastatic | Chemotherapy Effect | Chemotherapeutic Toxicity

China
Academisch Medisch Centrum - Universiteit van Amsterdam...
ZonMw: The Netherlands Organisation for Health Research and Development; Dutch...

Completed

Adjuvant HIPEC in High Risk Colon Cancer (COLOPEC)

Colorectal Neoplasms | Peritoneal Neoplasms

Netherlands
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Hoffmann-La... and other collaborators

Completed

Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer

Neoplasm Metastasis | Colorectal Cancer

United States
Zhejiang Cancer Hospital

Not yet recruiting

Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

China
Hoffmann-La Roche

Active, not recruiting

A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction

Gastric Cancer | Gastroesophageal Junction Adenocarcinoma

China
National Cancer Institute, Egypt

Completed

Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer Patients

Toxicity | Survival | Clinical Response
Rigshospitalet, Denmark
Morten Ladekarl, MD, DMSc., Dept. of Oncology, Århus Sygehus, Århus

Terminated

Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

Denmark
Medical College of Wisconsin

Recruiting

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

Rectal Adenocarcinoma

United States
Fudan University

Not yet recruiting

An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal Cancer

Rectal Cancer

China
International Group of Endovascular Oncology

Unknown

Modified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric Cancer (MATURE)

Metastatic Gastric Cancer

Italy
Lin Chen

Unknown

SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric Cancer (RESONANCE)

Gastric Adenocarcinoma

China
Hospices Civils de Lyon

Completed

GRECCAR 8: Primary Tumor Resection in Rectal Cancer With Unresectable Metastasis (GRECCAR8)

Rectal Adenocarcinoma

France
Medical Research Council
University of Leeds

Completed

Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Colorectal Cancer

United Kingdom
UNICANCER

Terminated

Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery

Colorectal Cancer

France
Sidney Kimmel Comprehensive Cancer Center at Johns...
Nucletron

Completed

Chemoradiation or Brachytherapy for Rectal Cancer (CORRECT)

Rectal Cancer

United States
First Affiliated Hospital of Guangxi Medical University

Recruiting

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

Colonic Neoplasms | Neoadjuvant Therapy | Immune Checkpoint Inhibitors

China
Shanghai University of Traditional Chinese Medicine
Jiangsu Province Hospital of Traditional Chinese Medicine; RenJi Hospital

Completed

The Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric Cancer (CHANGE)

Gastric Cancer Stage IIIB | Gastric Cancer Stage IIIC

China
Fudan University

Not yet recruiting

Short-course Radiotherapy Combined With Chemotherapy and Pd-1 Inhibitor for Locally Advanced Colon Cancer(TORCH-C) (TORCH-C)

Locally Advanced Colon Cancer
Peking University Cancer Hospital & Institute

Unknown

Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen

Rectal Cancer

China
Akeso

Recruiting

A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors

Advanced Malignant Tumors

China
University of Chicago
National Cancer Institute (NCI)

Completed

Oxaliplatin in Treating Patients With Metastatic Bladder Cancer

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter

United States, Canada
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer

Endometrial Cancer

United States
European Organisation for Research and Treatment...

Terminated

Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy

Breast Cancer

France, Belgium, Slovenia, Israel, United Kingdom, Germany, Austria
Thrombosis Research Institute

Completed

Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT (GASTRANOX)

Gastric Cancer | Gastroesophageal Cancer

India
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States, Canada
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer

Cervical Cancer

United States, Canada
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer

Head and Neck Cancer

United States
St. Jude Children's Research Hospital
National Cancer Institute (NCI)

Completed

Oxaliplatin in Treating Children With Advanced Solid Tumors

Unspecified Childhood Solid Tumor, Protocol Specific

United States
Jenny Drott

Completed

Neurotoxic Symptoms in Adjuvant Chemotherapy in Patients With Colorectal Cancer

Colorectal Neoplasms

Sweden
Sanofi

Completed

Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal Cancer

Rectal Neoplasms
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Suspended

Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases (PACHA-01)

Colorectal Cancer

France
University of California, Davis
National Cancer Institute (NCI)

Completed

Oxaliplatin in Treating Patients With Metastatic Breast Cancer

Stage IV Breast Cancer

United States
Fudan University

Recruiting

Short-course Radiotherapy Combined With CapeOx and PD-1 Inhibitor After Local Excision for High-risk Early Rectal Cancer (TORCH-LE)

Rectal Cancer

China
Fudan University
The First Affiliated Hospital with Nanjing Medical University; Hubei Cancer... and other collaborators

Unknown

Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1 (CinClare)

Locally Advanced Rectal Cancer

China
SCRI Development Innovations, LLC
Aventis Pharmaceuticals; Sanofi-Synthelabo

Completed

Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer

Esophagus Cancer

United States
Zhongshan Hospital Xiamen University

Unknown

Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer

Hepatic Metastasis of Colorectal Cancer

China
Sun Yat-sen University
Chengdu Biostar Pharmaceuticals

Not yet recruiting

Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms | Locally Advanced or Metastatic Breast Cancer

China
Sixth Affiliated Hospital, Sun Yat-sen University
Sun Yat-sen University

Recruiting

S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction Adenocarcinoma

Chemotherapy Effect | Locally Advanced Gastroesophageal Junction Adenocarcinoma

China
Hasselt University
Ziekenhuis Oost-Limburg

Unknown

Concentration- Versus Body Surface Area-based HIPEC in Colorectal Peritoneal Carcinomatosis' Treatment (COBOX)

Colorectal Peritoneal Carcinomatosis

Belgium
Samsung Medical Center

Unknown

Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy

Colon Cancer

Korea, Republic of
National Cancer Institute (NCI)
NSABP Foundation Inc

Completed

Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Liver Metastases | Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Adenocarcinoma of the Rectum | Adenocarcinoma of the Colon

United States
National Cancer Institute (NCI)

Completed

Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction

Liver Disease

United States
Samsung Medical Center

Unknown

Study of LV5FU2 Versus FOLFOX for Curatively-resected, Node-positive Esophageal Squamous Cell Carcinoma

Curatively-resected, Node-positive Esophageal Squamous Cell Carcinoma

Korea, Republic of
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction

Unspecified Adult Solid Tumor, Protocol Specific

United States
Sanofi

Completed

Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function (FOLFOX4)

Gastrointestinal Cancer

United States
Cheryl Pugh

Completed

Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer

Colorectal Cancer

United Kingdom, Cyprus
Grupo Espanol Multidisciplinario del Cancer Digestivo
Royal Marsden NHS Foundation Trust

Completed

Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum

Rectum Cancer

Spain
Australasian Gastro-Intestinal Trials Group
National Health and Medical Research Council, Australia; European Organisation... and other collaborators

Active, not recruiting

Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma (TOPGEAR)

Gastric Cancer

Australia, New Zealand
Centre Hospitalier Universitaire de Besancon

Terminated

Evaluation of Polychemotherapy With XELOXIRI-3 in Elderly or Frail Patients With Advanced Pancreatic Adenocarcinoma (ALIX)

Metastatic Pancreatic Adenocarcinoma

France

Search clinical trials for: Oxaliplatin capecitabine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations